BGF World Healthscience D4 EUR/ LU1728553774 /
| NAV7/1/2022 | Chg.+0.0600 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 15.4600USD | +0.39% | paying dividend | Equity Worldwide | BlackRock (LU) ▶ |
- Dividends adjusted Dividends adjusted
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 | - | - | -3.50 | 2.38 | 2.13 | 1.39 | 4.11 | 4.31 | 2.71 | -6.07 | 4.59 | -7.35 | - |
| 2019 | 4.74 | 3.23 | 0.27 | -3.12 | -1.66 | 7.02 | 2.19 | -0.15 | -1.38 | 4.80 | 4.33 | 3.03 | +25.30% |
| 2020 | -0.15 | -8.37 | -2.79 | 11.66 | 3.82 | -1.43 | 5.94 | 1.27 | -1.35 | -4.83 | 8.10 | 3.78 | +14.84% |
| 2021 | 1.82 | -2.58 | 1.43 | 4.83 | 1.09 | 2.47 | 1.91 | 1.76 | -4.35 | 2.18 | -2.32 | 6.36 | +15.05% |
| 2022 | -8.21 | -0.51 | 6.17 | -3.33 | -1.50 | -2.16 | 0.39 | - | - | - | - | - | - |
Single months: Dividends not considered
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 19.20% | 19.28% | 15.66% | 16.98% | -% |
| Sharpe ratio | -0.92 | -0.77 | -0.31 | 0.62 | - |
| Best month | +6.36% | +6.17% | +6.36% | +11.66% | +11.66% |
| Worst month | -8.21% | -8.21% | -8.21% | -8.37% | -8.37% |
| Maximum loss | -15.60% | -15.35% | -15.60% | -26.10% | - |
| Outperformance | +0.53% | - | -1.16% | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| BGF World Healthscience A2 AUD H | reinvestment | 20.2400 | -6.77% | +25.79% | |
| BGF World Healthscience A2 HKD H | reinvestment | 208.1500 | -6.11% | +30.53% | |
| BGF World Healthscience A2 SGD H | reinvestment | 20.6600 | -6.01% | +28.80% | |
| BGF World Healthscience C2 EUR | reinvestment | 45.1300 | +6.26% | +37.68% | |
| BGF World Healthscience A2 CNH H | reinvestment | 178.8500 | -3.94% | +37.30% | |
| BGF World Healthscience D2 USD | reinvestment | 67.8000 | -5.06% | +34.26% | |
| BGF World Healthscience D2 EUR | reinvestment | 65.1900 | +8.43% | +46.20% | |
| BGF World Healthscience D4 EUR | paying dividend | 15.4600 | -5.04% | +34.26% | |
| BGF World Healthscience X2 USD | reinvestment | 75.8100 | -4.12% | +38.31% | |
| BGF World Healthscience E2 USD | reinvestment | 54.6500 | -6.24% | +29.32% | |
| BGF World Healthscience A4 EUR | paying dividend | 11.0100 | +7.52% | - | |
| BGF World Healthscience A4 USD | paying dividend | 11.4600 | -5.76% | - | |
| BGF World Healthscience A2 EUR H | reinvestment | 13.6900 | -7.12% | +24.68% | |
| BGF World Healthscience E2 EUR | reinvestment | 52.5400 | +7.07% | +40.82% | |
| BGF World Healthscience A2 USD | reinvestment | 60.6900 | -5.78% | +31.25% | |
| BGF World Healthscience A2 EUR | reinvestment | 58.3500 | +7.60% | +42.94% |
Performance
| YTD | -9.33% | ||
|---|---|---|---|
| 6 Months | -7.65% | ||
| 1 Year | -5.04% | ||
| 3 Years | +34.26% | ||
| 5 Years | - | ||
| Since start | +55.90% | ||
| Year | |||
| 2021 | +15.05% | ||
| 2020 | +14.84% | ||
| 2019 | +25.30% | ||
Dividends
| 8/31/2020 | 0.02 USD |
| 8/30/2019 | 0.03 USD |
| 8/31/2018 | 0.05 USD |